We are just now, in February, beginning to see the signs of a recovery. As you can see on the snapshot of the chart below, the stock has just started to come off of being oversold and bounce off of its lowest PPS since August. The MACD also appears to be converging for an upcoming cross, and there’s a gap to the upside as well.
We’ll look to take advantage of this setup by tracking the F 03/02 10.37-11.37 Calls in the days and weeks ahead.
BioMarin Pharmaceutical, Inc. BMRN
Another potential bottom play we want to look at this morning is BMRN, which also recently has been beaten down to what we feel are unsustainable low levels. We’re getting a heavy multiple-bottom signal as the strength index is tumbling toward extremely oversold territory.
The look of the MACD suggests some further decrease or sideways trading could occur, which is why we’ll want to look at a set of extended term options contracts, the BMRN 03/16 $80 & 85 Calls. With over a month until expiration, that should give us ample time for the stock to realize the recovery it appears to be building toward.
AQMS, DO, NXTD, NGD, FNN, NOG, MARA, HMNY,